Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: PawPr who wrote (678)	5/28/1998 5:17:00 PM
From: FNS	Read Replies (2) of 965

RE; Imnx's drug...ok, got it! In regards to Avakine RA studies vs IMNX's drug, I recall having some contrary indication concerns w/Avakine while reading some of the result info quite some time ago... will have to do homework here. Nice part is that current input is favorable and revenue projections for 2000 ($2.00 @ 35 PE) make CNTO a great company. Does anyone know if the panel recommended a particular labeling indication? I.e., 'active', or moderate, severe, or both? Will see what CNTO has to say tonite! FNS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next